HANNAH GASPERONI: Open Payments
NPI 1861063158 · WINCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 41 payments from 14 companies in 2025. Trend: 2023 $2,038 · 2024 $2,165 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $166 |
| GENZYME CORPORATION | 5 | $140 |
| Novartis Pharmaceuticals Corporation | 4 | $112 |
| Amgen Inc. | 3 | $85 |
| Lilly USA, LLC | 3 | $75 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $68 |
| Janssen Biotech, Inc. | 2 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Incyte Corporation | 2 | $52 |
| Botanix SB Inc | 2 | $48 |
Products named: DUPIXENT, SKYRIZI, Otezla, TALTZ, ILUMYA, TREMFYA, Sotyktu, RINVOQ.
Industry payments across MA — which companies pay providers there.
